Response to: 'Additional proposals to reduce comorbidity in patients with chronic inflammatory rheumatic diseases'. Screening for comorbidities: what is the remit of rheumatologists?
Department of Rheumatology, GREPI-UGA EA7408, Grenoble, France.
Athan
A
Baillet
Department of Rheumatology, Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Paris, France.
Laure
0000-0002-4528-310X
L
Gossec
Department of Rheumatology, Paris Descartes University,-Hôpital Cochin. Assistance Publique-Hôpitaux de Paris. INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France.
Maxime
M
Dougados
D018501:Antirheumatic Agents; D015897:Comorbidity; D006801:Humans; D012216:Rheumatic Diseases; D000072140:Rheumatologists
D018501:Antirheumatic Agents
Disease Activity; Inflammation; Rheumatoid Arthritis